Cite
APA Citation
Hommes, D. W., Mikhajlova, T. L., Stoinov, S., Štimac, D., Vucelic, B., Lonovics, J., Zákuciová, M., D'Haens, G., Van Assche, G., Ba, S., Lee, S., & Pearce, T. (2006). fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut, 55(8), 1131–1137. http://access.bl.uk/ark:/81055/vdc_100137793524.0x000048